v3.26.1
Schedule of Segment Information (Details) - USD ($)
$ in Thousands
 3 Months Ended
Mar. 28, 2026
Mar. 29, 2025
Segment Reporting [Line Items]    
Total Revenues $ 4,712 $ 4,849
Total Gross profit 3,574 1,926
Total Operating loss (2,743) (1,946)
Corporate and other (506) (720)
Total Interest (expense) income, net 506 720
Total Net income (loss) before income taxes (356,396) (1,687)
Continuing Operations and Discontinued Operations [Member]    
Segment Reporting [Line Items]    
Total Revenues 4,712 4,849
Total Gross profit 3,574 1,926
Total Operating loss (2,920) (1,946)
Total Depreciation and amortization 888 1,210
Corporate and other 506 720
Total Interest (expense) income, net (506) (720)
Total Net income (loss) before income taxes (356,574) (1,687)
Fintech [Member] | Continuing Operations [Member]    
Segment Reporting [Line Items]    
Total Revenues 4,712 4,849
Total Gross profit 3,574 1,926
Total Operating loss (1,638) (138)
Total Depreciation and amortization 888 728
Corporate and other (379) (376)
Total Interest (expense) income, net 379 376
Total Net income (loss) before income taxes 1,631 543
Biotech [Member] | Discontinued Operations [Member]    
Segment Reporting [Line Items]    
Total Revenues
Total Gross profit
Total Operating loss (177) (540)
Total Depreciation and amortization 482
Corporate and other
Total Interest (expense) income, net
Total Net income (loss) before income taxes (177) (540)
Corporate Segment and Other Operating Segment [Member] | Continuing Operations [Member]    
Segment Reporting [Line Items]    
Total Revenues
Total Gross profit
Total Operating loss (1,105) (1,268)
Total Depreciation and amortization
Corporate and other (127) (344)
Total Interest (expense) income, net 127 344
Total Net income (loss) before income taxes $ (358,028) $ (1,690)